These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34339934)

  • 1. Evaluation of the in vitro susceptibility of various filarial nematodes to emodepside.
    Hübner MP; Townson S; Gokool S; Tagboto S; Maclean MJ; Verocai GG; Wolstenholme AJ; Frohberger SJ; Hoerauf A; Specht S; Scandale I; Harder A; Glenschek-Sieberth M; Hahnel SR; Kulke D
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():27-35. PubMed ID: 34339934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human filariasis-contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model.
    Risch F; Ritter M; Hoerauf A; Hübner MP
    Parasitol Res; 2021 Dec; 120(12):4125-4143. PubMed ID: 33547508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodepside has sex-dependent immobilizing effects on adult Brugia malayi due to a differentially spliced binding pocket in the RCK1 region of the SLO-1 K channel.
    Kashyap SS; Verma S; Voronin D; Lustigman S; Kulke D; Robertson AP; Martin RJ
    PLoS Pathog; 2019 Sep; 15(9):e1008041. PubMed ID: 31553770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filarial nematode phenotypic screening cascade to identify compounds with anti-parasitic activity for drug discovery optimization.
    Hawryluk N; Zhiru L; Carlow C; Gokool S; Townson S; Kreiss T; Chojnowski A; Prorok M; Siekierka J; Ehrens A; Koschel M; Lhermitte-Vallarino N; Martin C; Hoerauf A; Hernandez G; Canan S; Khetani V; Zeldis J; Specht S; Hübner MP; Scandale I
    Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():89-97. PubMed ID: 35834918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
    Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections.
    Greene SE; Fischer K; Choi YJ; Curtis KC; Budge PJ; Mitreva M; King CL; Fischer PU; Weil GJ
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010407. PubMed ID: 35604906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethylcarbamazine elicits Ca
    Williams PDE; Kashyap SS; Robertson AP; Martin RJ
    Antimicrob Agents Chemother; 2023 Oct; 67(10):e0041923. PubMed ID: 37728916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.
    Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M
    Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration.
    Krücken J; Holden-Dye L; Keiser J; Prichard RK; Townson S; Makepeace BL; Hübner MP; Hahnel SR; Scandale I; Harder A; Kulke D
    PLoS Pathog; 2021 Jul; 17(7):e1009682. PubMed ID: 34293063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bma-LAD-2, an Intestinal Cell Adhesion Protein, as a Potential Therapeutic Target for Lymphatic Filariasis.
    Flynn AF; Taylor RT; Pazgier ME; Bennuru S; Lindrose AR; Sterling SL; Morris CP; Gleeson BI; Maugel TK; Nutman TB; Mitre E
    mBio; 2022 Jun; 13(3):e0374221. PubMed ID: 35475643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental infection of humans with filariae.
    Nutman TB
    Rev Infect Dis; 1991; 13(5):1018-22. PubMed ID: 1962076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic trial of doxycyclin plus ivermectin for the treatment of Brugia malayi naturally infected cats.
    Khowawisetsut L; Sarasombath PT; Thammapalo S; Loymek S; Korbarsa T; Nochote H; Phuakrod A; Choochote W; Wongkamchai S
    Vet Parasitol; 2017 Oct; 245():42-47. PubMed ID: 28969836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylcarbamazine mediated potentiation of emodepside induced paralysis requires TRP-2 in adult Brugia malayi.
    Kashyap SS; McHugh MA; Robertson AP; Martin RJ
    Int J Parasitol Drugs Drug Resist; 2022 Dec; 20():108-112. PubMed ID: 36368250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current perspective of new anti-Wolbachial and direct-acting macrofilaricidal drugs as treatment strategies for human filariasis.
    Ehrens A; Hoerauf A; Hübner MP
    GMS Infect Dis; 2022; 10():Doc02. PubMed ID: 35463816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a long-read metabarcoding platform for the detection of filarial worm pathogens of animals and humans.
    Huggins LG; Atapattu U; Young ND; Traub RJ; Colella V
    BMC Microbiol; 2024 Jan; 24(1):28. PubMed ID: 38245715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First study of topical selamectin efficacy for treating cats naturally infected with Brugia malayi and Brugia pahangi under field conditions.
    Sarasombath PT; Thammapalo S; Loymek S; Angkanasinsiri A; Priyavoravong P; Wongkamchai S
    Parasitol Res; 2019 Apr; 118(4):1289-1297. PubMed ID: 30746583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling cross-reactivity of anti-glycan IgG responses in filarial nematode infections.
    Petralia LMC; van Diepen A; Nguyen DL; Lokker LA; Sartono E; Bennuru S; Nutman TB; Pfarr K; Hoerauf A; Wanji S; Foster JM; Hokke CH
    Front Immunol; 2023; 14():1102344. PubMed ID: 36949937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodepside targets SLO-1 channels of Onchocerca ochengi and induces broad anthelmintic effects in a bovine model of onchocerciasis.
    Bah GS; Schneckener S; Hahnel SR; Bayang NH; Fieseler H; Schmuck GM; Krebber R; Sarr A; Terjung C; Ngangyung HF; Ekale DD; Mfopit YM; Rufener L; Graham-Brown J; Tanya VN; Glenschek-Sieberth M; Kulke D; Makepeace BL
    PLoS Pathog; 2021 Jun; 17(6):e1009601. PubMed ID: 34077488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.
    Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA
    Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filariasis research - from basic research to drug development and novel diagnostics, over a decade of research at the Institute for Medical Microbiology, Immunology and Parasitology, Bonn, Germany.
    Karunakaran I; Ritter M; Pfarr K; Klarmann-Schulz U; Debrah AY; Debrah LB; Katawa G; Wanji S; Specht S; Adjobimey T; Hübner MP; Hoerauf A
    Front Trop Dis; 2023 Mar; 4():. PubMed ID: 38655130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.